TY - JOUR T1 - Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01725-2017 VL - 50 IS - 4 SP - 1701725 AU - Robert P. Baughman AU - Oksana A. Shlobin Y1 - 2017/10/01 UR - http://erj.ersjournals.com/content/50/4/1701725.abstract N2 - Patients with advanced sarcoidosis may develop pulmonary hypertension for a variety of reasons [1]. One of the earlier papers noting the incidence and severity of this problem came from the clinic run by Gianfranco Rizzato in Milan [2]. Despite the well documented association noted in that article, there were very few reports of sarcoidosis-associated pulmonary hypertension (S-APH) until 20 years later. Over the past 10 years, reports regarding S-APH have come from the USA [3–5], Europe [1, 6, 7] and Japan [8]. These studies found that S-APH was most frequently seen patients with fibrotic disease and was associated with increased mortality [9, 10].More evidence that sarcoidosis patients with pulmonary hypertension respond to therapy http://ow.ly/H40c30fetN4 ER -